Hauptthema: Die ischaemische Herzkrankheit

  • W. Kübler
  • H. Blömer
  • G. Mall
  • I. Siemens
  • R. Zimmermann
  • A. Schömig
  • P. Schanzenbächer
  • P. R. Lichtlen
  • H. Tillmanns
  • W. Kübler
  • E. Hoberg
  • Th. Nordt
  • I. Ott
  • A. Schömig
  • W. Bircks
  • B. Maisch
  • W. Bleifeld
  • W. Terres
  • H. Kreuzer
  • G. Ertl
  • P. Gaudon
  • C. Eilles
  • K. Kochsiek
Conference paper
Part of the Verhandlungen der Deutschen Gesellschaft für Innere Medizin book series (VDGINNERE, volume 97)

Zusammenfassung

Die kardiovaskuläre Morbidität und Mortalität in den Industrienationen ist — vor allem beim männlichen Geschlecht — wesentlich durch ischämische Erkrankungen des Myokards bestimmt [18]. Ursächlich steht die Atherosklerose der epikardialen Koronar­arterien an erster Stelle, die zu Stenosen und Verschlüssen der Gefäße führen kann.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Anversa P, Ricci R, Olivetti G (1987) Effects of exercise on the capillary vasculature of the rat heart. Circulation 75 (suppl I): 12–18Google Scholar
  2. 2.
    Davies MJ, Thomas T (1981) The pathological basis and microanatomy of occlusive thrombus formation in human coronary arteries. Phil Trans R Soc Lond B 294: 225–229CrossRefGoogle Scholar
  3. 3.
    Doerr W (1972) Pathologie der CoronargeffBe. Anthropologische Aspekte. Sitzungsberichte der Heidelberger Akademie der Wissenschaften Mathematisch-naturwissenschaftliche Klasse. 2. Abhandlung. Springer, Berlin Heidelberg New YorkGoogle Scholar
  4. 4.
    Doerr W (1979) Unspezifische Entzündungen: Koronaritis. Deutsches Ärzteblatt 32: 2033–2038Google Scholar
  5. 5.
    Doerr W (1983) Pathologisch-anatomische Definition der Arteriosklerose. Theorien Zur Entstehung der Arteriosklerose. Deutsches Ärzteblatt Ärztliche Mitteilungen. Sonderdruck 20: 33–43Google Scholar
  6. 6.
    Gertz D, Kalan JM, Kragel AH, Roberts WC, Braunwald E (1990) Gardiac morphologic findings in patients with acute myocardial infarction treated with recombinant tissue plasminogen activator. Am J Cardiol 65: 953–961PubMedCrossRefGoogle Scholar
  7. 7.
    Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ (1987) Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316: 1371–1375PubMedCrossRefGoogle Scholar
  8. 8.
    Ishii T, Newman WP, Guzman MA, Hosoda Y, Strong JP (1986) Coronary and aortic atherosclerosis in young men from Tokyo and New Orleans. Lab Invest 54: 561–565PubMedGoogle Scholar
  9. 9.
    Liu MW, Roubin GS, King SB (1989) Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation 79: 1374–1384PubMedCrossRefGoogle Scholar
  10. 10.
    Silver MD (1983) Cardiovascular pathology. Churchill Livingstone, New York Edinburgh London MelbourneGoogle Scholar
  11. 11.
    Mall G, Greber D, Gharebhaghi H, Wiest G, Mattfeldt T, Ganten U (1991) Myokardprotektion und Hypertrophie-regression bei spontan hypertensiven Ratten durch Nifedipin und Moxonidin stereologische Untersuchungen In: Ganten D, Mall G ( 1991 ) Herz-Kreislauf-Regulation, Organprotektion und Organschäden. Schattauer, Stuttgart New York, pp 91–105Google Scholar
  12. 12.
    Pesonen E, Norio R, Sarna S (1975) Thickenings in the coronary arteries in infancy as an indication of genetic factors in coronary heart disease. Circulation 51: 218–225PubMedCrossRefGoogle Scholar
  13. 13.
    Potkin BN, Roberts WC (1988) Effects of percutaneous transluminal coronary angioplasty on atherosclerotic plaques and relation of plaque composition and arterial size to outcome. Am J Cardiol 62: 41–50PubMedCrossRefGoogle Scholar
  14. 14.
    Rahlf G (1985) Morphologie der intramuralen Koronararterien bei Herzhypertrophien. In: Mall G, Otto HF ( 1985 ) Herzhypertrophie. Springer, Berlin Heidelberg New York Tokio, S 144–167Google Scholar
  15. 15.
    Ross R (1986) The pathogenesis of atherosclerosis an update. N Engl J Med 314: 488–500PubMedCrossRefGoogle Scholar
  16. 16.
    Schettler G (1985) Gangarten der Arteriosklerose. In: Mall G, Otto HF ( 1985 ) Herzhypertrophie. Springer, Berlin Heidelberg New York Tokio: 134–143Google Scholar
  17. 17.
    Sims FH, Gavin JB, Vanderwee MA (1989) The intima of human coronary arteries. Am Heart J 118: 32–38PubMedCrossRefGoogle Scholar
  18. 18.
    Sytkowski PA, Kannel WB, D’Agostino RB (1990) Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham heart study. N Engl J Med 322: 1635–1641Google Scholar
  19. 19.
    Tracy RE, Devaney K, Kissling G (1985) Characteristics of the plaque under a coronary thrombus. Virch Arch A 405: 411–427CrossRefGoogle Scholar
  20. 20.
    Tracy RE, Kissling GE, Lopez CR, Gandia M (1986) Histometric components of aortic atherosclerosis which vary or remain constant among eight populations. Lab Invest 54: 314–321PubMedGoogle Scholar
  21. 21.
    Virmani R, Forman MB (1989) Nonatherosclerotic ischemic heart disease. Raven Press, New YorkGoogle Scholar
  22. 1.
    Arnold et al. (1985) Inotropic stimulation of reperfused myocardium: effect on myocardial function. J Am Coll Cardiol 6: 1026–1034PubMedCrossRefGoogle Scholar
  23. 2.
    Ballantyne CM et al. (1987) Delayed recovery of severely „stunned“ myocardium with the support of a left ventricle device after coronary artery bypass graft sugery. J Am Coll Cardiol 10: 710–712PubMedCrossRefGoogle Scholar
  24. 3.
    Bolli et al. (1985) Beta adrenergic stimulation reverses post-ischemic myocardial dysfunction. Am J Cardiol 56: 964–968PubMedCrossRefGoogle Scholar
  25. 4.
    Bolli R (1990) Mechanism of myocardial „stunning“. Circulation 82: 723–738PubMedCrossRefGoogle Scholar
  26. 5.
    Braunwald E, Kloner RA (1982) The stunned myocardium: prolonged postischemic left ventricular dysfunction. Circulation 66: 1146–1149PubMedCrossRefGoogle Scholar
  27. 6.
    Brill DA et al. (1988) Recovery of servere ischemic ventricular dysfunction after coronary artery bypass grafting. Am J Cardiol 81: 850–851Google Scholar
  28. 7.
    Camici P et. al. (1986) Increased uptake of F18-deoxyglucose in postischemic moycardium of patients with exercise-induced angina. Circulation 74: 81–88PubMedCrossRefGoogle Scholar
  29. 8.
    Dilsizian V et al. (1990) Enhanced detection of ischemic but viable myocardium by reinjection of thallium after stress redistribution imaging. N Eng J Med 323: 141–147CrossRefGoogle Scholar
  30. 9.
    Ellis SG et al. (1983) Time course of functional and biochemical recovery of myocardium salvaged by reperfusion. J Am Coll Cardiol 1: 1047–1055PubMedCrossRefGoogle Scholar
  31. 10.
    Engler R (1983) Leukozyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Physiol 111: 98–111Google Scholar
  32. 11.
    Gibson RS et al. (1983) Prospective assessement of regional myocardial perfusion before and after coronary revascularization by thallium-201 szintigraphy. J Am Coll Cardiol 1: 804812Google Scholar
  33. 12.
    Klocke FJ et al. (1974) Average coronary blood flow per unit weight of left ventricle in patients with and without coronary artery disease. Circulation 50: 547–559PubMedCrossRefGoogle Scholar
  34. 13.
    Klocke FJ et al. (1977) Myocardial blood flow determined with helium desaturation and great cardiac vein/coronary sinus sampling in patients with left anterior descending artery stenosis. Herz 2: 15–11Google Scholar
  35. 14.
    Klocke FJ (1983) Measurements of coronary blood flow and degree of stenosis. Current clinical implications and continuing uncertainties. J Am Coll Cardiol 1: 31–41PubMedCrossRefGoogle Scholar
  36. 15.
    Kloner RA et al. (1989) Altered myocardial states. Am J Med 86 (suppl. 1A): 14–22PubMedCrossRefGoogle Scholar
  37. 16.
    Krause SM et al. (1986) Alterations in sarcoplasmatic reticulum Cat+ transport in post-ischemic stunned myocardium (abstr.). Circulation 74: 11–67Google Scholar
  38. 17.
    Kusuoka H et al. (1987) Pathophysiology of stunned myocardium. J Clin Invest 79: 950 961Google Scholar
  39. 18.
    Liu P et al. (1985) The persistent defect on exercise thallium imaging and its fate after myocardial revascularization. Does it represent scar or ischemia? Am Heart J 111: 996–1002CrossRefGoogle Scholar
  40. 19.
    Marban E (1991) Myocardial stunning and hibernation. Circulation 83: 681–688PubMedCrossRefGoogle Scholar
  41. 20.
    Marshall RC et al. (1983) Identification and differentiation of resting myocardial ischemia and infarctions in mean with PET. Circulation 67: 766–778PubMedCrossRefGoogle Scholar
  42. 21.
    Matsuzaki M et al. (1983) Sustained regional dysfunction produced by prolonged coronary stenosis. Circulation 68: 170–182PubMedCrossRefGoogle Scholar
  43. 22.
    McCord JM (1985) Oxygeno-derived free radials in postischemic tissue injury. N Engl J Med 312: 159–163PubMedCrossRefGoogle Scholar
  44. 23.
    Nesto RW et al. (1982) Inotropic contractile reserve: a useful predictor of increased 5 year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction. Am J Cardiol 50: 39–44PubMedCrossRefGoogle Scholar
  45. 24.
    Nixon JV et al. (1982) Identification of transient and persistent segmental wall motion abnormalities in patients with instable angina. Circulation 65: 1497–1503PubMedCrossRefGoogle Scholar
  46. 25.
    Ohtani H et al. (1990) Value of Thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 66: 394–399PubMedCrossRefGoogle Scholar
  47. 26.
    Patch B et al. (1988) Postischemic myocardial stunning: a clinical relevant phenomenon. Ann Intern Med 108: 626–628CrossRefGoogle Scholar
  48. 27.
    Popio KA et al. (1977) Postextrasystolic potentiation as a predictor of potential myocardial viability. Am J Cardiol 39: 944–953PubMedCrossRefGoogle Scholar
  49. 28.
    Preuss KC et al. (1987) Time course of recovery of stunned myocardium following variable periods of ischemia. Am Heart J 114: 696–703PubMedCrossRefGoogle Scholar
  50. 29.
    Przyklenk K, Kloner RA (1986) Superoxid dismutase plus katalase improve contractile function in the canine model of stunned myocardium. Circ Res 58: 148–156PubMedCrossRefGoogle Scholar
  51. 30.
    Rahimtoola SH (1985) A perspective on the three large multicenter randomized clinical trials of coronary artery bypass surgery for chronic stable angina pectoris. Circulation 72: V123 - V135PubMedCrossRefGoogle Scholar
  52. 31.
    Rahimtoola SH (1989) The hibernating myocardium. Am Heart J 117: 211–221PubMedCrossRefGoogle Scholar
  53. 32.
    Renkin J et al. (1991) Reversal of segmental hypokinesis by coronary angioplasty in patients with unstable angina, persistent T wave inversion, and LAD coronary artery stenosis. Additional evidence for myocardial stunning-humans. Circulation 82: 913–921CrossRefGoogle Scholar
  54. 33.
    Robertson WS (1983) Exercise echocardiography: a clinical practical addition in the evaluation of coronary artery disease. J Am Coll Cardiol 2: 1085–1091PubMedCrossRefGoogle Scholar
  55. 34.
    Tamaki N et al. (1989) Positron Emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Caridol 64: 861–865Google Scholar
  56. 35.
    Tennant R, Wiggers CJ (1935) The effect of coronary occlusion on myocardial contraction. J Physiol 112: 351–361Google Scholar
  57. 36.
    Tillisch J et al. (1986) Reversibility of cardiac wall-motion abnormalities predicted by PET. N Engl J Med 314: 884–888PubMedCrossRefGoogle Scholar
  58. 1.
    Block PC (1990) Restenosis after percutaneous transluminal coronary angioplasty anatomic and pathophysiological mechanisms. Strategies for prevention. Circulation 81 (suppl IV):IV-2-IV-4Google Scholar
  59. 2.
    The TIMI Study Group (1989) Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. N Engl J Med 320: 618–27CrossRefGoogle Scholar
  60. 3.
    McBride W, Lange RA, Hillis LD (1988) Restenosis after successful coronary angioplasty. Pathophysiology and prevention. N Engl J Med 318: 1734–7Google Scholar
  61. 4.
    ACC/AHA Task Force Report (1988) Guidelines for percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 12: 529–45Google Scholar
  62. 5.
    Meier B (1988) Restenosis after coronary angioplasty: review of the literature. Eur Heart J 9 (suppl C): 1–6PubMedCrossRefGoogle Scholar
  63. 6.
    Laarman GJ, Planté S, de Feyter PJ (1990) PTCA of chronically occluded coronary arteries. Am Heart J 119: 1153–60PubMedCrossRefGoogle Scholar
  64. 7.
    Warren RJ, Black Ai, Valentine FA, Manolas EG, Hunt D (1990) Coronary angioplasty for chronic total ooclusion reduces the need for subsequent coronary bypass surgery. Am Heart J 120: 270–4PubMedCrossRefGoogle Scholar
  65. 8.
    Fanelli C, Aronoff R (1990) Restenosis following coronary angioplasty. Am Heart J 119: 357–68PubMedCrossRefGoogle Scholar
  66. 9.
    Liu MW, Roubin GS, King III SB (1989) Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation 79: 1374–87Google Scholar
  67. 10.
    Ellis SG, Roubin GS, King III SB, Douglas JS, Cox WR (1989) Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneus transluminal coronary angioplasty. Am J Cardiol 63: 30–4PubMedCrossRefGoogle Scholar
  68. 11.
    Quigley PJ, Hlatky MA, Hinohara T et al. (1989) Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis. Am J Cardiol 63: 409–13PubMedCrossRefGoogle Scholar
  69. 12.
    Rapold HJ, David PR, Guiteras Val P, Mata AL, Crean PA, Bourassa MG (1987) Restenosis and its determinants in first and repeat coronary angioplasty. Eur Heart J 8: 575–86PubMedGoogle Scholar
  70. 13.
    Guiteras Val P, Bourassa MG, David PR et al. (1987) Restenosis after successful percutaneous transluminal coronary angioplasty: The Montreal Heart Institute experience. Am J Cardiol 60: 50B - 55BGoogle Scholar
  71. 14.
    Black AJR, Anderson HV, Roubin GS, Powelson SW, Douglas JS, King III SB (1988) Repeat coronary angioplasty: Correlates of a second restenosis. J Am Coll Cardiol 11: 714–8Google Scholar
  72. 15.
    Lambert M, Bonan R, Coté G et al. (1988) Multiple coronary angioplasty: A model to discriminate systemic and procedural factors related to restenosis. J Am Coll Cardiol 12: 310–4PubMedCrossRefGoogle Scholar
  73. 16.
    Teirstein PS, Hoover CA, Ligon RW et al. (1989) Repeat coronary angioplasty: Efficacy of a third angioplasty for a second restenosis. J Am Coll Cardiol 13: 291–6PubMedCrossRefGoogle Scholar
  74. 17.
    Leimgruber PP, Roubin GS, Hollman J et al. (1986) Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 73: 710–7PubMedCrossRefGoogle Scholar
  75. 18.
    Barnathan ES, Schwartz JS, Taylor L et al. (1987) Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty. Circulation 76: 125–34PubMedCrossRefGoogle Scholar
  76. 19.
    Schwartz L, Bourassa MG, Lespérance J et al. (1988) Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 318: 1714–9PubMedCrossRefGoogle Scholar
  77. 20.
    Thornton HA, Grüntzig AR, Holtman J, King III SB, Douglas JS (1984) Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized trial. Circulation 69: 721–7PubMedCrossRefGoogle Scholar
  78. 21.
    Knudtson ML, Flintoft VA, Roth DL, Hansen JL, Duff HJ (1990) Effect of short-term prostacyclin administration on restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 15: 691–7PubMedCrossRefGoogle Scholar
  79. 22.
    Ellis SG, Roubin GS, Wilentz J, Douglas JS, King III SB (1989) Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 117: 777–82PubMedCrossRefGoogle Scholar
  80. 23.
    Urban P, Buller N, Fox K, Shapiro L, Bayliss J, Rickards A (1988) Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon coronary angioplasty. Br Heart J 60: 485–8PubMedCrossRefGoogle Scholar
  81. 24.
    Grigg LE, Kay TWH, Valentine PA et al. (1989) Determinants of restenosis and lack of effect or dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty. J Am Coll Cardiol 13: 665–72PubMedCrossRefGoogle Scholar
  82. 25.
    Dehmer GJ, Popma JJ, van den Berg EK et al. (1988) Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med 319: 733–40PubMedCrossRefGoogle Scholar
  83. 26.
    Reis GJ, Boucher TM, Sipperly ME et al. (1989) Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet 1989 11: 177–81CrossRefGoogle Scholar
  84. 27.
    Milner MR, Gallino RA, Leffingwell A et al. (1989) Usefulness of fish oil supplements in preventing clinical evidence of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 64: 29–49CrossRefGoogle Scholar
  85. 28.
    Hoberg E, Schwarz F, Schömig A et al. (1990) Prevention of restenosis by verapamil. The Verapamil Angioplasty Study (VAS). Circulation 82 (suppl III): III - 428Google Scholar
  86. 29.
    Spears JR (1987) Percutaneous transluminal coronary angioplasty restenosis: Potential prevention with laser balloon angioplasty. Am J Cardiol 60: 61B - 64BPubMedCrossRefGoogle Scholar
  87. 30.
    Simpson JB, Zimmerman JJ, Selmon MR et al. (1986) Transluminal atherectomy: initial results in 27 patients. Circulation 74 (suppl II) II - 203Google Scholar
  88. 31.
    Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L (1987) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316: 701–6PubMedCrossRefGoogle Scholar
  89. 32.
    Schömig A, Brachmann J, Wilhelm C et al. (1990) Recanalization of femoropopliteal occlusions by argon and excimer laser-balloon angioplasty. Eur Heart J 11 (suppl): 82Google Scholar
  90. 33.
    Litvack F, Grundfest WS, Segalowitz J et al. (1990) Interventional cardiovascular therapy by laser and thermal angioplasty. Circulation 81 (suppl IV):IV-109-IV-116Google Scholar
  91. 34.
    Karsch KR, Haase KK, Voelker W, Baumbach A, Mauser M, Seipel L (1990) Percutaneous coronary excimer laser angioplasty in patients with stable and unstable angina pectoris. Acute results and incidence of restenosis during 6-month follow-up. Circulation 81: 1849–59PubMedCrossRefGoogle Scholar
  92. 35.
    Simpson JB, Rowe MH, Selmon MR et al. (1990) Restenosis following directional coronary atherectomy in de novo lesions of native coronary arteries. Circulation 82 (suppl III) III - 313Google Scholar
  93. 1.
    Azariades M, Fessler CL, Floten H St, Starr A (1990) Five-year results of coronary bypass grafting for patients older than 70 years: role of internal mammary artery. Ann Thorac Surg 50: 940–945PubMedCrossRefGoogle Scholar
  94. 2.
    Banner HB, Standeven JW, Reese J (1985) Twelve-year experience with internal mammary artery for coronary artery bypass. J Thorac Cardiovasc Surg 90: 668–675Google Scholar
  95. 3.
    Bircks W (1990) Herzchirurgie Vergangenheit, Gegenwart, Zukunft. Z Kardiol 79, suppl 4: 1–5Google Scholar
  96. 4.
    CASS principal investigators and their associates (1983) Coronary Artery Study (CASS); a randomized trial of coronary artery bypass surgery: survival data. Circulation 68: 939–950CrossRefGoogle Scholar
  97. 5.
    Frankl WS (1990) A comparison of coronary artery bypass surgery and percutaneous transluminal coronary angioplasty in the treatment of coronary angioplasty in the treatment of coronary artery disease. Modern Concepts of Cardiovascular Disease (American Heart Association) 59: 31–42Google Scholar
  98. 6.
    Galotti R, Mamolo G, Casucci R, Maslowsky F, Gross C, Ornaghi D, Panisi P, Semeraro F, Respighi E (1991) Reoperation for myocardial revascularization using the internal mammary artery. J Cardiovasc Surg 32: 8–11Google Scholar
  99. 7.
    Groudin CM (1984) Late results of coronary artery grafting: is there a flag in the field? J Thorac Cardiovasc Surg 87: 161–166Google Scholar
  100. 8.
    Hall RJ (1989) Coronary artery bypass in perspective. Texas Heart Institute, Journal 16: 127–130Google Scholar
  101. 9.
    Ivert TK, Huttunen K, Landou C, Björk VO (1988) Angiographic studies of internal mammary artery grafts 11 years after coronary artery bypass grafting. J Thorac Cardiovasc Surg 96: 1–12PubMedGoogle Scholar
  102. 10.
    Kalmar P, Irrgang E (1990) Cardiac Surgery in the Federal Republic of Germany during 1989, a report by the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surgn 38: 198–200CrossRefGoogle Scholar
  103. 11.
    Kalmar P (1991) Persönliche Mitteilung, basierend auf einer noch nicht publizierten Erfassung der Deutschen Ges. f. Thorax-, Herz-and Gefäßchirurgie. Thorac Cardiovasc SurgnGoogle Scholar
  104. 12.
    Killtip T, Passamani E, Davis K, CASS principal investigators and their associates (1985) A randomized trial of coronary bypass surgery. Eight years follow-up and survival in patients with reduced ejection fraction. Circulation 72 (suppl V): 105–109CrossRefGoogle Scholar
  105. 13.
    Lytle BW, Loop FD, Cosgrove DM, Ratcliffe NB, Easley K, Taylor PC (1985) Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg 89: 248–258PubMedGoogle Scholar
  106. 14.
    McGrath LB, Laub GW, Graf D, Gonzales-Lavin L (1990) Hospital death on a cardiac surgical service: negative influence of changing practice patterns. Ann Thorac Surg 49: 410–412PubMedCrossRefGoogle Scholar
  107. 15.
    Rich MW, Keller AJ, Schechtman KB, Marshall WG, Kouchoukos NT (1988) Morbidity and mortality of coronary bypass surgery in patients 75 years of age or older. Ann Thorac Surg 46: 638–644PubMedCrossRefGoogle Scholar
  108. 16.
    Schaff V, Gersh BJ, Fisher LD, Frye RL, Mock MB, Ryan JT, Eis RB, Chaitman BR, Alderman EL, Kaiser GC (1984) Detrimental effect of perioperative myocardial infarction on late survival after coronary artery bypass. Report from the Coronary Artery Surgery Study CASS. J Thorac Cardiovasc Surg 88: 972–981PubMedGoogle Scholar
  109. 17.
    Schröder T, Hörmann E, Leitz K, Engel H-J (1990) Die sofortige Bypass-Operation verhindert den Herzinfarkt beim PTCA-Notfall. Z Kardiol 79: 669–676PubMedGoogle Scholar
  110. 18.
    Takaro T, Hultgren HN, Detre KM, Peduzzi P (1982) The Veterans Administration Cooperative Study of stable angina: Current status. Circulation 65 (suppl II): 60–67PubMedCrossRefGoogle Scholar
  111. 19.
    Varnauskas E, European Coronary Surgery Study group (1988) Twelve-year follow-up of survival in the randomized European Coronary Artery Surgery Study. N Engl J Med 1988: 332–337Google Scholar
  112. 20.
    Vukmirovic NB, Bircks W (1990) Die Bedeutung der Arteria mammaria interna als BypassgefäB. Dt Ärztebl 87: 4105–4112Google Scholar
  113. 1.
    Arnim T von, Szeimies-Seebach U, Erath A, Schreiber MA, Höfling B (1989) Transient ischemic episodes a marker for future cardiac events in patients with stable angina pectoris. In: Arnim T, von, Maseri, A (eds) Predisposing conditions for acute ischemic syndromes, Steinkopff, Darmstadt; Springer, Berlin Heidelberg New York Tokyo, pp 117–125CrossRefGoogle Scholar
  114. 2.
    Arnim T von (1987) Silent ischemia in patients with coronary heart disease: prevalence and prognostic implications. Eur Heart J 8 (Suppl G): 115–118PubMedCrossRefGoogle Scholar
  115. 3.
    Bairey CN, Rozanski A, Maddahi J, Resser KJ, Berman DS (1989) Exercise Thallium-201 scintigraphy and prognosis in typical angina pectoris and negative exercise electrocardiograpiy. Am J Cardiol 64: 282–287PubMedCrossRefGoogle Scholar
  116. 4.
    Beller GA (1987) Role of nuclear cardiology in evaluating the total ischemic burden in coronary artery disease. Am J Cardiol 59:31C–38CCGoogle Scholar
  117. 5.
    Cecchi AC, Dovellini EV, Marchi F, Pucci P, Santoro GM, Fazzini PF (1983) Silent myocardial ischemia during ambulatory electrocardiographic monitoring in patients with effort angina. J Am Coll Cardiol 1: 934–939PubMedCrossRefGoogle Scholar
  118. 6.
    Chatterjee K (1989) Ischemia-Silent or manifest: Does it matter? (Editorial comment) J Am Coll Cardiol 13: 1503–1505CrossRefGoogle Scholar
  119. 7.
    Chiariello, M (1985) Asymptomatic transient ST changes during ambulatory ECG monitoring in diabetic patients. Am Heart J 110: 529–534PubMedCrossRefGoogle Scholar
  120. 8.
    Cohn PF (1980) Silent myocardial ischemia in patients with a defective anginal warning system. Amer J Cardiol 45: 697–702PubMedCrossRefGoogle Scholar
  121. 9.
    Cohn PF (1983) Prognosis and treatment of asymptomatic coronary artery disease. J Am Coll Cardiol. 1: 959–964PubMedCrossRefGoogle Scholar
  122. 10.
    Cohn PF (1989) Prognosis in exercise-induced silent) ischemia: Is there a consensus? J Am Coll Cardiol 14: 893–4PubMedCrossRefGoogle Scholar
  123. 11.
    Cohn PF (1984) Time for a new approach to management of patients with both symptomatic and asymptomatic episodes of myocardial ischemia. Am J Cardiol 54: 1358–1359PubMedCrossRefGoogle Scholar
  124. 12.
    Cohn PF (1985) Silent myocardial ischemia: Classification, prevalence, and prognosis. Am J Med 79:Suppl. 3A: 2–6Google Scholar
  125. 13.
    Cohn PF (1985) Silent myocardial ischemia as a manifestation of asymptomatic coronary artery disease: What is appropriate therapy? Am J Cardiol 56: 28D - 34DPubMedCrossRefGoogle Scholar
  126. 14.
    Cohn PF (1987) Silent myocardial ischemia and infarction. Dekker, New York–Goy, KM; Imperi, GA, Lambert, CR, Pepine CJ (1987) Silent myocardial ischemia during daily activities in asymptomatic men with positive exercise test responses. Am J Cardiol 59: 45–49CrossRefGoogle Scholar
  127. 15.
    Deanfield JE, Kensett M, Wilson RA, Shea M, Horlock P, Landsheere CM de, Selwyn AP (1984) Silent myocardial ischaemia due to mental stress. Lancet 2: 1001–1004PubMedCrossRefGoogle Scholar
  128. 16.
    Deanfield JE, Ribeiro P, Oakley K, Krikler S, Selwyn AP (1984) Analysis of ST-Segment changes in normal subjects: Implications for ambulatory monitoring in angina pectoris. Am J Cardiol 54: 1321–1325Google Scholar
  129. 17.
    Deanfield JE, Selwyn AP, Chierchia S, Maseri M, Ribeiro P, Krikler S (1983) Myocardial life ischaemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet 2: 753–758PubMedCrossRefGoogle Scholar
  130. 18.
    Deedwania PC, Carbajal EV (1990) Silent ischemia during daily life is an independent predictor of morality in stable angina. Circulation 81: 748–756PubMedCrossRefGoogle Scholar
  131. 19.
    Deedwania PC, Carbajal EV (1990) Exercise test predictors of ambulatory silent ischemia during daily life in stable angina pectoris. Am J Cardiol 66: 1151–1156PubMedCrossRefGoogle Scholar
  132. 20.
    Deedwania PC, Nelson JR (1990) Pathophysiology of silent myocardial ischemia during daily life. Hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring. Circulation 82: 1296–1304Google Scholar
  133. 21.
    Droste G, Roskamm H (1983) Experimental pain measurement in patients with asymptomatic myocardial ischemia. J Am Coll Cardiol 1: 940–945PubMedCrossRefGoogle Scholar
  134. 22.
    Droste C (1984) Asymptomatische Myokardischämie, In: Roskamm H. (Hrsg) Handbuch der inneren Medizin Bd IX73: Koronarerkrankungen. S 613–642Google Scholar
  135. 23.
    Droste C (1987) Pathophysiologie schmerzhafter and stummer Myokardischämie. Herz 12: 369–386PubMedGoogle Scholar
  136. 24.
    Ellestadt MH, Kuan P (1984) Naloxone and symptomatic ischemia: Failure to induce angina during exercise testing. Am J Cardio 54: 982–984Google Scholar
  137. 25.
    Erikssen J, Enge J, Forfang K, Storstein O (1976) False-positive diagnostic tests and coronary angiographic findings in 105 presumably healthy males. Circulation 54: 371–376PubMedCrossRefGoogle Scholar
  138. 26.
    Faerman I, Faccio E, Milei J (1977) Autonomic neuropathy and painless myocardial infarction in diabetic patients: histologic evidence of their relationship. Diabetes 26: 1147–1158PubMedCrossRefGoogle Scholar
  139. 27.
    Fisch S (1980) On the origin of cardiac pain. Arch Intern Med 140: 754–755PubMedCrossRefGoogle Scholar
  140. 28.
    Freeman LJ, Nixon PGF, Sallabank P, Reaveley D (1987) Psychological stress and silent myocardial ischemia. Am Heart J 114: 477–482PubMedCrossRefGoogle Scholar
  141. 29.
    Frishman WH, Teicher M (1987) Antianginal drug therapy tor silent myocardial ischemia. Am Heart J 114Google Scholar
  142. 30.
    Fox K (1986) The choice of therapy in chronic ischaemic heart disease. Symposium: Cardioprotection in ischaemic heart disease: Fact or Fantasy? Basel, 18. JanuarGoogle Scholar
  143. 31.
    Fox K (1987) Should we treat silent ischaemia? J Cardiovasc Pharmacol 10 (Suppl. 2): S34 - S36PubMedGoogle Scholar
  144. 32.
    Giagnoni E, Secchi MB, Wu SC, Morabito A, Oltrona I, Mancarella S, Volpin N, Fossa L, Bettazzi L, Arangio G, Sachero A, Folli G (1983) Prognostic value of exercise EKG testing in asymptomatic normotensive subjects: A prospective matched study. N Eng J Med 309: 1085–1089Google Scholar
  145. 33.
    Gottlieb SO, Ouyang P, Mellits ED, Gerstenblith G (1985) Silent ischemia during medical therapy predicts unfavorable outcomes in unstable angina. Circulation 72: 111–163Google Scholar
  146. 34.
    Gottlieb SO, Weisfeldt ML, Ouyand P, Mellits ED, Gerstenblith G (1986) Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med 314: 1214–1219PubMedCrossRefGoogle Scholar
  147. 35.
    Gottlieb SO, Weisfeldt ML, Ouyand P, Mellits ED, Gerstenblith G (1987) Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina. J Am Coll Cardiol 10: 756–760PubMedCrossRefGoogle Scholar
  148. 36.
    Grauer K (1990) Silent myocardial ischemia: dilemma or blessing? Am Fam Physician 42 (Suppl): 13S - 16SPubMedGoogle Scholar
  149. 37.
    Grossman A (1984) Endorphins and exercise. Clin Cardiol 7: 255–260PubMedGoogle Scholar
  150. 38.
    Hausdorf K (1987) Ergometrie and stumme Ischämie Winch Med Wschr 38: 664–667Google Scholar
  151. 39.
    Hausmann D, Nikutta P, Daniel WG, Wenzlaff P, Lichten P (1991) Determinanten für das Auftreten von Ischämie-Episoden im Langzeit-EKG bei Patienten mit positivem Belastungs-EKG. Z Kardiol 80 (Suppl. 3 ): 24 (A62)Google Scholar
  152. 40.
    Hecht HS, Shaw RE, Bruce T, Myler RK (1989) Silent ischemia: Evaluation by exercise and redistribution tomographic thallium-201 myocardial imaging. J Am Coll Cardiol 14: 895–900PubMedCrossRefGoogle Scholar
  153. 41.
    Hendel RG, Layden JJ, Leppo JA (1990) Prognostic value of dipyridamole thallium scintigraphy for evaluation of ischemic heart disease. J Am Coll Cardiol 15: 109–116PubMedCrossRefGoogle Scholar
  154. 42.
    Hoberg E, Schwarz F, Kibler W (1987) Stumme Ischämien bei stabiler Angina pectoris. Dtsch Med Wschr 112: 1197–1200PubMedCrossRefGoogle Scholar
  155. 43.
    Imperi GA, Lambert CR, Coy K, Lopez L, Pepine CJ (1987) Effects of titrated beta blockade (metoprolol) on silent myocardial ischemia in ambulatory patients with coronary artery disease. Am J Cardiol 60: 519–524PubMedCrossRefGoogle Scholar
  156. 44.
    Juul-Möller S, Hedblad HO, Svensson K, Hanson BS, Isacsson SO, Janzon L, Lindell SE, Steen B, Johannsson (1989) Prognostic information carried by ST segment depressions and arrhythmias in a cohort from a general population. Circulation 80: 615Google Scholar
  157. 45.
    Kannei WB, Abbott RD (1984) Incidence and prognosis of unrecognized myocardial infarction: An update on the Framingham Study. N Engl J Med 311: 1144–1147Google Scholar
  158. 46.
    Kennedy HL, Underhill SJ, Caralis DG, Khan MA, Poblete PF (1976) Detection of non-anginal or silent ischemic ST-segment depression in patients with ischemic heart disease. Am J Cardiol 37: 147CrossRefGoogle Scholar
  159. 47.
    Kowalchuk GJ, Nesto RW (1989) Silent myocardial ischemia-mechanisms and rationale for therapy. Am J Med, 86 (Suppl 1A): 9–13PubMedCrossRefGoogle Scholar
  160. 48.
    Lind P, Eber B, Bitner G, Költringer P, Brandt D, Klein W, Eber O (1990) 201-Tl myocardial spect and I3-endorphin levels in patients with suspected silent ischemia. Nucl-Med 29: 153–157Google Scholar
  161. 49.
    Löllgen H (1987) Stille Myokardischämie and ergometrische Belastungsuntersuchung. Schwerpunktmed 10: 17–24Google Scholar
  162. 50.
    Mark DB, Hlatky MA, Califf RM, Morris JJ, Sisson SD, McCants CB, Lee KL, Harrel FE, Pryor DB (1989) Painless exercise ST deviation on the treadmill: Long-term prognosis. J Am Coll Cardiol 14: 885–892Google Scholar
  163. 51.
    Maseri A (1983) The changing face of angina pectoris: Practical implications. Lancet I: 746–749Google Scholar
  164. 52.
    Maseri A, Chierchia S, Davies G, Glazier J (1985) Mechanisms of ischemic cardiac pain and silent myocardial ischemia. Am J Med 79; Suppl 3A: 7–11Google Scholar
  165. 53.
    Muller JE, Ludmer PL, Willich SN, Tofler GH, Aylmer G, Klangos I, Stone PH (1987) Circadian variation in the frequency of sudden cardiac death. Circulation 75: 131–138PubMedCrossRefGoogle Scholar
  166. 54.
    Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker G, Poole K, Passamani E, Roberts R, Robertson R, Sobel BE, Willerson JT, Braunwald E (1985) Milis Study Group: Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 21: 1315–1322Google Scholar
  167. 55.
    Multiple Risk Factor Intervention Trial Research Group (1985) Exercise electrocardiogram and coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Am J Cardiol 55: 16–24CrossRefGoogle Scholar
  168. 56.
    Nademanee K, Intarachot V, Piontek M, Vaghaiwalla M, Mody D, Josephson M, Singh BN (1984) Relationship by myocardial ischemia detected by compact Holter analog technique to that induced by ETT. Circulation 70: 11–451Google Scholar
  169. 57.
    Nademanee K, Intarachot V, Piontek M, Vaghaiwalla M, Mody D, Raider M, Josephson M, Singh BN (1984) Silent myocardial ischemia on Holter: Has it clinical or prognostic significance? Circulation 70: 11–451Google Scholar
  170. 58.
    Nademanee K, Intarachot V, Josephson MA, Rieders D, Mody D, Vahaiwalla F, Singh, BN (1987) Prognostic significance of silent myocardial ischemia in patients with unstable angina. J Am Coll Cardiol 10: 1–9PubMedCrossRefGoogle Scholar
  171. 59.
    Nesto RW, Kett KJ (1988) Silent myocardial ischemia in the diabetic patient. In: Singh, B.N. (ed.). Silent myocardial ischemia and angina. Pergamon, New York Oxford Beijing Frankfurt Sao Paulo Sydney Tokyo Toronto, pp 126–133Google Scholar
  172. 60.
    Ouyang P, Shapiro EP, Chjandra NC, Gottlieb SH, Chew PH, Gottlieb SO (1987) An angiographic and functional comparison of patients with silent and symptomatic treadmill ischemia early after myocardial infarction. Am J Cardiol 59: 730–734PubMedCrossRefGoogle Scholar
  173. 61.
    Parodi O, Simonetti I, Michelassi C, Carpeggiani C, Biagni A, L’Abbate A, Maseri A (1986) Comparison of verapamil and propranolol therapy for angina pectoris at rest. A randomized, multiple-crossover, controlled trial in the coronary care unit. Am J Cardiol 57: 899–906Google Scholar
  174. 62.
    Pasternack PF, Gross EA, Baumann FG, Riles TS, Lamparello PJ, Giangola G, Lawrence KP, Mintzer R, Imparato AM (1989) Beta-blockade to decrease silent myocardial ischemia during peripheral vascular surgery. Am J Surg 158: 113–116PubMedCrossRefGoogle Scholar
  175. 63.
    Pohost GM (1989) „Silent Ischemia“: What is it? Editorial Comment. J Am Coll Cardiol 14, 901–2PubMedCrossRefGoogle Scholar
  176. 64.
    Previtali M, Salerno J, Tavazzi L, Ray M, Medici A, Chimienti M, Specchia B, Bobba P (1980) Treatment of angina at rest with nifedipine: a short-term controlled study. Am J Cardiol 45: 825–830PubMedCrossRefGoogle Scholar
  177. 65.
    Prinzmetal M, Ekmekei N, Kennamer R, Kwoczynski JK, Shubin H, Toyoshima H (1960) Variant form of angina pectoris. Previously undelineated syndrome. JAMA 174: 1794–1800Google Scholar
  178. 66.
    Raby KE, Goldman L, Creager MA, Cook EF, Weiberg MC, Whitemore AD, Selwyn AP (1989) Correlations between preoperative ischemia and major cardiac events after peripheral vascular surgery. N Engl J Med 321: 1296–1300PubMedCrossRefGoogle Scholar
  179. 67.
    Rozanski A, Berman DS (1987) Silent myocardial ischemia. I. Pathophysiology, frequency of occurence, and approaches toward detection. Am Heart J 114: 615–626Google Scholar
  180. 68.
    Rozanski A, Berman DS (1987) Silent myocardial ischemia. II Prognosis and implications for the clinical assessment of patients with coronary artery disease. Am Heart J 114: 627–638Google Scholar
  181. 69.
    Scheler S, Motz W, Strauer BE (1989) Transiente Myokardischämien bei Hypertonikern. Z Kardio178: 1987–203Google Scholar
  182. 70.
    Sharma B, Asinger R, Francis GS, Hodges M, Wyeth RP (1987) Demonstration of exercise-induced painless myocardial ischemia in survivors of out-of-hospital ventricular fibrillation. Am J Cardiol 59: 740–745PubMedCrossRefGoogle Scholar
  183. 71.
    Shea MJ, Deanfield JE, Wilson R, Landsheere C de, Jones T, Selwyn AP (1985) Transient ischemia in angina pectoris: frequent silent events with everyday activities. Am J Cardiol 56: 34E - 38EPubMedCrossRefGoogle Scholar
  184. 72.
    Shepard JT (1985) The heart as a sensory organ. J Am Coll Cardiol 6: 83B - 87BCrossRefGoogle Scholar
  185. 73.
    Sheps DS, Heiss G (1989) Sudden death and silent myocardial ischemia. Am Heart J 117: 177–184PubMedCrossRefGoogle Scholar
  186. 74.
    Sheps DS, Adams KF, Hinderliter A, Price G, Bissette J, Orlando G, Margolis B, Koch G (1987) Endorphins are related to pain perception in coronary artery disease. Am J Cardiol 59: 523–527PubMedCrossRefGoogle Scholar
  187. 75.
    Silber S, Vogler A (1986) Die stumme Myokardischämie: Dimensionierung eines Problems. Intensivmed 23: 52–63Google Scholar
  188. 76.
    Stern S, Tzivoni D (1974) Early detection of silent ischemic heart disease by 24-hour electrocardiographic monitoring of active subjects. Br Heart J 36: 481–486PubMedCrossRefGoogle Scholar
  189. 77.
    Stern S, Tzivoni D, Stern Z (1975) Diagnostic accuracy of ambulatory ECG monitoring in ischemic heart disease. Circulation 52: 1045–1049PubMedCrossRefGoogle Scholar
  190. 78.
    Stone PH (1987) Calcium antagonists for Prinzmetal’s variant angina, unstable angina and silent myocardial ischemia: Therapeutic tool and probe for identification of pathophysiologic mechanisms. Am J Cardiol 59: 101B - 115BPubMedCrossRefGoogle Scholar
  191. 79.
    Stone GW, Spaude S, Ligon RW, Hartzler GO (1989) Usefulness of percutaneous transluminal coronary angioplasty in alleviating silent myocardial ischemia in patients with absent or minimal painful myocardial ischemia. Am J Cardiol 64: 560–564PubMedCrossRefGoogle Scholar
  192. 80.
    Theroux P, Waters DD, Halphen C, Debaisieux J-G, Mizgala HF (1979) Prognostic value of exercise testing soon alter myocardial infarction. N Engl J Med 301: 341–345PubMedCrossRefGoogle Scholar
  193. 81.
    Tzivoni D, Benhorin J, Gavish A, Stern S (1985) Holter recording during treadmill testing in assessing myocardial ischemic changes. Am J Cardiol 55: 1200–1203PubMedCrossRefGoogle Scholar
  194. 82.
    Tzivoni D, Stern S (1990) Editorial: Prognostic significance an therapeutic implications of silent myocardial ischaemia. Eur Heart J 11: 288–293Google Scholar
  195. 83.
    Wall EE van der, Cats V, Blokland KAL, Bosker JA, Arndt JW, Pauwels EKJ, Bruschke AVG (1989) The effects of diltiazem on cardiac function in silent ischemia after myocardial infarction. Am Heart J 118: 655–661PubMedCrossRefGoogle Scholar
  196. 84.
    Weiner DA, Ryan TJ, McCabe CH, Ng G, Chaitman BR, Sheffield T, Tristani FE, Fisher LD (1989) The role of exercise-induced silent myocardial ischemia in patients with abnormal left ventricular function. A report from the Coronary Artery Surgery Study ( CASS) registry. Am Heart J 118: 649–654Google Scholar
  197. 85.
    Whitaker MP, Sheps DS (1989) Prevalence of silent myocardial ischemia in survivors of cardiac arrest. Am J Cardiol 64: 591–593PubMedCrossRefGoogle Scholar
  198. 86.
    Wohlgelernter D, Jaffe CC, Gabin HS, Yeatman LA, Gleman M (1987) Silent ischemia during coronary occlusion produced by balloon inflation: relation to regional myocardial dysfunction. J Am Coll Cardiol 10: 491–498PubMedCrossRefGoogle Scholar
  199. 87.
    Yasue S (1979) Circadian variation of exercise capacity in patients with Prinzmetal’s variant angina: Role of exercise-induced coronary arterial spasm. Circulation 59: 938–948PubMedCrossRefGoogle Scholar
  200. 88.
    Yeung AC, Barry J, Selwyn AP (1990) Silent ischemia alter myocardial infarction. Prognosis, mechanism, and intervention. Circulation 82 (suppl I):11–143–11–148Google Scholar
  201. 89.
    Yurenev AP, DeQuattro V, Devereux RB (1990) Hypertensive heart disease: Relationship of silent ischemia to coronary artery disease and left ventricular hypertrophy. Am. Heart J. 120: 928–933, 1990Google Scholar
  202. 1.
    Kannel WB, Sortie P, McNamara PM (1979) Prognosis after myocardial infarction. The Framingham Study. Am J Cardiol 44: 31–59Google Scholar
  203. 2.
    Gorlin R Incidence, etiology, and prognosis of heart failure. Cardiovascular Reviews and Reports 1983 4: 765–769Google Scholar
  204. 3.
    Pfeffer MA, Braunwald E (1990) Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81: 1161–1172Google Scholar
  205. 4.
    Taylor GJ, Humphries JO, Mellits ED, Pitt B, Schulze RA, Griffith LSC, Achuff SC (1980) Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction. Circulation 62: 960–969PubMedCrossRefGoogle Scholar
  206. 5.
    White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RML, Wild CJ (1987) Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76: 44–51PubMedCrossRefGoogle Scholar
  207. 6.
    Parmley WW, Chatterjee K (1986) Congestive heart failure and arrhythmias: An overview. Am J Cardiol 57: 34B - 37BPubMedCrossRefGoogle Scholar
  208. 7.
    Gulch RW, Jacob R (1988) Geometric and muscle physiological determinantes of cardiac stroke volume as evaluated on the basis of model calculations. Basic Res Cardiol 83: 476–485PubMedCrossRefGoogle Scholar
  209. 8.
    Ertl G, Gaudron P, Eilles Chr, Schorb W, Kochsiek K (1991) Compensatory mechanisms for cardiac dysfunction in myocardial infarction. Basic Res Cardiol (im Druck )Google Scholar
  210. 9.
    Gaudron P, Eilles C, Ertl G, Kochsiek (1990) Early remodelling of the left ventricle in patients with myocardial infarction. Eur Heart J 11 ( Suppl. B), 139–146Google Scholar
  211. 10.
    Maisch B, Ertl G, Eilles C, Gerhards W, Knoblauch J, Kochsiek K (1985) Left ventricular function during VVI and DVI pacing at different rates as assessed by m-mode and two-dimensional echocardiography, gated single photon emission computerized tomography (GASPECT) and thermodilution. In: Behrenbeck DW, Sorston E, Fontaine G, Winter UJ (ed) Cardiac Pacemakers, Steinkopff, Darmstadt 158–169CrossRefGoogle Scholar
  212. 11.
    Jeremy RW, Hackworthy RA, Bautovich G, Hutton BF, Harris PJ (1987). Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. J Am Coll Cardiol 9: 989–995PubMedCrossRefGoogle Scholar
  213. 12.
    Hochman JS, Choo H (1987) Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 75: 299–306PubMedCrossRefGoogle Scholar
  214. 13.
    Waris EK, Siitonen L, Himanka E (1966) Heart size and prognosis in myocardial infarction. Am Heart J 71: 187–195PubMedCrossRefGoogle Scholar
  215. 14.
    Marino P, Zanolla L, Zardini P (1989) Effect of strepokinase on left ventricular modeling and function after myocardial infarction: The GISSI ( Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico) Trial. J Am Coll Cardiol 14: 1149–1158PubMedCrossRefGoogle Scholar
  216. 15.
    ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2: 349–360Google Scholar
  217. 16.
    CASS Principal Investigators and Their Associates (1988) Myocardial infarction and mortality in the Coronary Artery Surgery Study (CASS) randomized trial. N Engl J Med 310: 750–758Google Scholar
  218. 17.
    Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E (1988) Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 319: 80–86PubMedCrossRefGoogle Scholar
  219. 18.
    Sharpe N, Murphy J, Smith M, Hannan S (1988) Treatment of patients with symptomless left ventricular dysfunction after mycordial infarction. Lancet 1: 255–259PubMedCrossRefGoogle Scholar
  220. 19.
    Jugdutt BI, Warnica JW (1988) Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Circulation 78: 906–919PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • W. Kübler
    • 1
  • H. Blömer
    • 2
  • G. Mall
    • 3
  • I. Siemens
    • 3
  • R. Zimmermann
    • 4
  • A. Schömig
    • 5
  • P. Schanzenbächer
    • 6
  • P. R. Lichtlen
    • 7
  • H. Tillmanns
    • 8
  • W. Kübler
    • 9
  • E. Hoberg
    • 9
  • Th. Nordt
    • 9
  • I. Ott
    • 9
  • A. Schömig
    • 9
  • W. Bircks
    • 10
  • B. Maisch
    • 11
  • W. Bleifeld
    • 12
  • W. Terres
    • 12
  • H. Kreuzer
    • 13
  • G. Ertl
    • 14
  • P. Gaudon
    • 14
  • C. Eilles
    • 14
  • K. Kochsiek
    • 14
  1. 1.HeidelbergDeutschland
  2. 2.MünchenDeutschland
  3. 3.Pathologisches InstitutUniversität HeidelbergDeutschland
  4. 4.Medizinische KlinikUniversität HeidelbergDeutschland
  5. 5.Abteilung Innere Medizin III, Medizinische KlinikUniversität HeidelbergDeutschland
  6. 6.Medizinische KlinikUniversität WürzburgDeutschland
  7. 7.Abteilung für KardiologieMedizinische Hochschule HannoverDeutschland
  8. 8.Abteilung Innere Medizin Kardiologie, Medizinische KlinikUniversität GießenDeutschland
  9. 9.Abteilung Innere Medizin III, Medizinische KlinikUniversität HeidelbergDeutschland
  10. 10.Abteilung für Thorax-und kardiovaskuläre Medizin, Chirurgische Klinik und PoliklinikUniversität DüsseldorfDeutschland
  11. 11.Abteilung Innere Medizin KardiologieUniversität MarburgDeutschland
  12. 12.Abteilung für Kardiologie, Medizinische KlinikUniversitätskrankenhaus EppendorfHamburgDeutschland
  13. 13.Medizinische KlinikUniversität GöttingenDeutschland
  14. 14.Medizinische KlinikUniversität WürzburgDeutschland

Personalised recommendations